[email protected]
CDI - Contrive Datum Insights
Medical Devices

Dental Restorative Market Size, Growth Rate and Regional Share Forecast to 2034

Dental restorative revenue grows from USD 24.2 billion in 2025 to USD 43.2 billion by 2034 at 6.55%, with growth concentrated in restorative equipment and North America.

Published: Industry: Medical DevicesRead time: ~5 min

The dental restorative market is a USD 24.2 billion business in 2025 and is forecast to reach USD 43.2 billion by 2034. The rate between those two points is 6.55%. This analysis sets out what that rate rests on, where it could fail, and which products and regions carry it.

The data comes from CDI's forecast covering 2026 to 2034, built on a history that runs from 2020 to 2024.

Market size and growth rate

Revenue was USD 16.9 billion in 2020 and USD 22.6 billion in 2024. The historical period compounded at 7.45%. The 2025 base year stands at USD 24.2 billion, and the forecast period then runs at 6.55%, ending 2034 at USD 43.2 billion.

The forecast rate sits below the historical one. It is also applied flat across the whole period instead of being ramped up or down year by year. That choice matters for a planner: the forecast does not assume a late acceleration to make the end figure work. It continues a series that has grown without a break for fifteen years.

The market covers seven product groups, from direct and indirect restorative materials to bonding agents, cements, liners and bases, and restorative equipment. It is also cut by restoration type, material class, fabrication method, curing mechanism, end user and several other axes. The product type axis is the one that explains most of the growth pattern below.

What is driving it

The growth rate is not shared evenly. Restorative Equipment grows at 10.67% against 6.55% for the market. Its revenue moves from USD 2.5 billion in 2025 to USD 6.3 billion in 2034, and its share of revenue from 10.33% to 14.58%. At the other end of the product axis, a line grows at 3.24%. The spread between those two rates is wide enough that the headline 6.55% is a weighted result, not a rate any single line achieves.

For a supplier, the consequence is direct. Exposure to restorative equipment, and not exposure to the market as a whole, determines the rate a business actually experiences. A portfolio weighted toward the slow end of the axis will track below the market even while the total grows every year.

Equipment lines outpacing their markets is not unique to dentistry. In the physiotherapy equipment market, the fastest product line, Shockwave Therapy Equipment, grows at 10.62% against 5.93% for the market. The pattern is the same: a small line with a high rate pulls the average up.

Geography supplies the second support. North America holds USD 8.71 billion in 2025, which is 36% of the global total, and USD 14.26 billion by 2034, still 33%. Europe holds 27%, with USD 6.53 billion rising to USD 10.58 billion. Most of the base sits in those two regions, so a plan spread evenly across all five over-invests outside them.

What could slow it

The downside case rests on four assumptions:

  • Patient affordability weakens.
  • Price competition from low-cost laboratories and imported zirconia deepens.
  • Digital adoption stalls in smaller clinics.
  • Coverage expansion is delayed.

On those assumptions, 2034 revenue lands at USD 39 billion against the USD 43.2 billion base case. The starting point is the same USD 24.2 billion in 2025. The market still grows in this case. What changes is the size of the 2034 total.

Two structural dependencies sit underneath the downside. The first is the largest line. Direct Restorative Materials holds 30.58% of 2025 revenue, USD 7.4 billion, and grows at only 5.26% against the market's 6.55%. It still reaches USD 11.9 billion by 2034, while its share falls to 27.55%. That is a drag on the average and not a decline. Because no other line on the axis carries comparable weight, anything that changes demand for direct materials changes the headline number.

The second is the concentration inside the leading region. The United States generates USD 7.6 billion of North America's USD 8.71 billion in 2025, which is 87.26% of the region, and reaches USD 12.2 billion by 2034. A reader who treats North America as a diversified region would miss that its number carries one country's reimbursement, pricing and practice conditions inside it.

The digital assumption in the restraint case has a parallel elsewhere in the portfolio. In the continuous glucose monitoring market, Software and Data Platforms compounds at 17.8% against 11.47% for the market. Digital layers are growing faster than the hardware around them in that report, which is the reverse of what a stall in smaller dental clinics would imply.

Where the growth sits

The upside path ends 2034 at USD 47 billion against the USD 43.2 billion base case, off the same 2025 starting point. It assumes dental visit rates recover above trend, digital chairside and printed workflows spread faster to smaller practices, and wider adult coverage lifts crown and implant restoration volumes.

By product type, 2025 shares are:

  • Direct Restorative Materials: 30.58%
  • Indirect Restorative Materials: 28.93%
  • Bonding Agents and Adhesives: 13.22%
  • Dental Cements: 10.74%
  • Restorative Equipment: 10.33%
  • Liners, Bases and Temporary Materials: 6.2%

The largest line is not the fastest. Restorative Equipment is the place on this axis where share changes hands at scale, so it is where an entrant can take position without displacing the incumbent in direct materials.

By region, global revenue is split as follows: North America 36%, Europe 27%, Asia Pacific 24%, Latin America 7% and Middle East and Africa 6%. North America leads at 36% of global revenue through 2034.

The picture across both axes is consistent. The base sits in direct materials and in North America, and the rate comes from restorative equipment. A forecast that holds at 6.55% needs the equipment line to hold its 10.67%, and a forecast that misses will most likely do so through affordability, laboratory pricing or slower digital adoption in smaller clinics. The full report carries the remaining segmentation axes, including restoration type, fabrication method, end user and treatment funding, for readers who need the same analysis at that level.